Remdesivir Shortens Time to Recovery in COVID19 (ACTT-1), CRP-Guided Antibiotics for Gram Negative Bacteremia, NT-pro-BNP in Syncope

We're back with another episode.  We cover the latest highlights in COVID, including the exciting new results on remdesivir from the ACTT-1 trial.  We also talk about whether you can use CRP to guide duration of antibiotic therapy in patients with gram negative bacteremia, and whether NT-pro-BNP can help you risk-stratify patients with syncope.  Check it out!


Remdesivir Shortens Time to Recovery in COVID19 (ACTT-1)

CRP Guided Antibiotics or 7 Days vs 14 Days for Gram Negative Bacteremia

NT-pro-BNP in Syncope









Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)

Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R